Literature DB >> 11524493

Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease.

A J Aksamit1, C M Preissner, H A Homburger.   

Abstract

CSF 14-3-3 and neuron-specific enolase (NSE) proteins were quantitated from patients who had Creutzfeldt-Jakob disease (CJD) or other rapidly dementing disorders initially considered to be CJD. Thirty-one patients were diagnosed as having CJD among 152 studied. CSF 14-3-3 values more than 8 ng/mL correlated with CJD. CSF NSE values less than 30 ng/mL and 14-3-3 values less than 8 ng/mL made a diagnosis of CJD unlikely, but did not exclude it.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11524493     DOI: 10.1212/wnl.57.4.728

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  Serum neuron-specific enolase level as a biomarker in differential diagnosis of seizure and syncope.

Authors:  Seung-Yeob Lee; Young-Chul Choi; Jeong-Ho Kim; Won-Joo Kim
Journal:  J Neurol       Date:  2010-06-08       Impact factor: 4.849

Review 2.  Clinical Laboratory Tests Used To Aid in Diagnosis of Human Prion Disease.

Authors:  Allyson Connor; Han Wang; Brian S Appleby; Daniel D Rhoads
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

3.  Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology.

Authors:  Taim Muayqil; Gary Gronseth; Richard Camicioli
Journal:  Neurology       Date:  2012-09-19       Impact factor: 9.910

4.  Cerebrospinal fluid neurone-specific enolase in mitochondrial encephalomyopathies.

Authors:  Josef Finsterer; Markus Exner; Helmut Rumpold
Journal:  Metab Brain Dis       Date:  2005-03       Impact factor: 3.584

Review 5.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Huidy Shu; Aissa Haman; James J Sejvar; Bruce L Miller
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

6.  Ovine serum biomarkers of early and late phase scrapie.

Authors:  Isabelle Batxelli-Molina; Nicolas Salvetat; Olivier Andréoletti; Luc Guerrier; Guillaume Vicat; Franck Molina; Chantal Mourton-Gilles
Journal:  BMC Vet Res       Date:  2010-11-02       Impact factor: 2.741

Review 7.  Clinical Use of Improved Diagnostic Testing for Detection of Prion Disease.

Authors:  Mark P Figgie; Brian S Appleby
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

8.  Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years.

Authors:  Katharina Stoeck; Pascual Sanchez-Juan; Joanna Gawinecka; Alison Green; Anna Ladogana; Maurizio Pocchiari; Raquel Sanchez-Valle; Eva Mitrova; Theodor Sklaviadis; Jerzy Kulczycki; Dana Slivarichova; Albert Saiz; Miguel Calero; Richard Knight; Adriano Aguzzi; Jean-Louis Laplanche; Katell Peoc'h; Gabi Schelzke; Andre Karch; Cornelia M van Duijn; Inga Zerr
Journal:  Brain       Date:  2012-09-25       Impact factor: 13.501

9.  Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study.

Authors:  Michael B Coulthart; Gerard H Jansen; Elina Olsen; Deborah L Godal; Tim Connolly; Bernard C K Choi; Zheng Wang; Neil R Cashman
Journal:  BMC Neurol       Date:  2011-10-27       Impact factor: 2.474

10.  Correlation between serum neuron specific enolase and functional neurological outcome in patients of acute ischemic stroke.

Authors:  Sana Zaheer; Mujahid Beg; Imran Rizvi; Najmul Islam; Ekram Ullah; Nishat Akhtar
Journal:  Ann Indian Acad Neurol       Date:  2013-10       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.